Insiders Updates A Guide To The Risks Of Investing In Lexaria Bioscience Corp (LEXX) Lexaria Bioscience Corp’s filing revealed that its Director BUNKA CHRISTOPHER acquired Company’s shares for reported $14375.0 on Jul 29 ’25.
Featured Lexaria Bioscience Corp. (LEXX) Stock Performing Steadily and Consistently Lexaria Bioscience Corp. (LEXX), a company operating in the drug delivery platform business, has steadily increased by 2.17% in aftermarket